failure to respond or late response
on 16 Jun 2022
Last Applicant/ Owned by
530 Fairview Avenue North
Seattle
WA
98109
Serial Number
87914539 filed on 09th May 2018
Registration Number
N/A
Correspondent Address
Alyssa Worsham
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
diagnostic reagents and instruments for medical or veterinary use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; diagnostic reagents for medical or veterinary use in the fields of cancer, neurology and infectious disease; diagnostic reagent kits comprising primarily of d Read More
diagnostic reagents and instruments for medical or veterinary use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; diagnostic reagents for medical or veterinary use in the fields of cancer, neurology and infectious disease; diagnostic reagent kits comprising primarily of diagnostic reagents for medical or veterinary use in the fields of cancer, neurology and infectious disease; chemical reagents for medical use; reagents for medical or veterinary use containing antibodies and nucleic acids; diagnostic test kits for medical use comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical or veterinary diagnostic kits comprising medical or veterinary diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; diagnostic preparations in the nature of antibodies, for medical and veterinary purposes; reagents and diagnostic reagents for medical or veterinary purposes; diagnostic preparations in the nature of in situ hybridization probes, for medical and veterinary purposes; medical or veterinary diagnostic reagents for pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; multiparameter quantitative detection and analysis products and technology for diagnostics for a variety of uses in health care, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; medical diagnostic reagents and assays for testing of body fluids or tissue; kits consisting primarily of medical or veterinary diagnostic reagents and assays for testing of body fluids or tissue; reagents in the form of cell markers and molecule markers including antibodies and nucleic acids for medical or veterinary purposes; medical diagnostic reagents for use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; medical diagnostic reagents for use relating to molecular identification and digital quantification; medical diagnostic reagents containing antibodies and nucleic acids; medical diagnostic reagents for use in the fields of cancer, neurology and infectious disease; medical diagnostic reagents for immuno-histochemistry detection and in situ-hybridization detection; medical diagnostic reagents for use relating to molecular identification and digital quantification
05th Sep 2018
05th Sep 2018
No 87914539
No Service/Collective Mark
No 31353-TM1042
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
16th Jun 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
16th Jun 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
03rd Dec 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
03rd Dec 2021 | NON-FINAL ACTION E-MAILED |
03rd Dec 2021 | SU - NON-FINAL ACTION - WRITTEN |
30th Aug 2021 | ASSIGNED TO EXAMINER |
19th Aug 2021 | ASSIGNED TO EXAMINER |
17th Aug 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
16th Aug 2021 | STATEMENT OF USE PROCESSING COMPLETE |
16th Aug 2021 | SOU EXTENSION 5 GRANTED |